Yize Li

3.2k total citations
39 papers, 1.7k citations indexed

About

Yize Li is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Yize Li has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 14 papers in Molecular Biology and 14 papers in Immunology. Recurrent topics in Yize Li's work include SARS-CoV-2 and COVID-19 Research (12 papers), interferon and immune responses (11 papers) and Animal Virus Infections Studies (10 papers). Yize Li is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), interferon and immune responses (11 papers) and Animal Virus Infections Studies (10 papers). Yize Li collaborates with scholars based in United States, China and Canada. Yize Li's co-authors include Susan R. Weiss, Robert H. Silverman, Stephen A. Goldstein, Beihua Dong, Christina Gaughan, Shuvojit Banerjee, Boyd L. Yount, Ralph S. Baric, Ruth Elliott and Courtney E. Comar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Yize Li

36 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yize Li United States 23 810 699 528 205 186 39 1.7k
Milan Surjit India 23 1.1k 1.3× 509 0.7× 297 0.6× 261 1.3× 129 0.7× 43 2.1k
Changfa Fan China 14 1.1k 1.3× 327 0.5× 169 0.3× 171 0.8× 105 0.6× 32 1.5k
Rebecca Penn United Kingdom 9 1.1k 1.4× 430 0.6× 197 0.4× 156 0.8× 65 0.3× 10 1.5k
Jin Wei China 20 596 0.7× 527 0.8× 573 1.1× 133 0.6× 154 0.8× 39 1.5k
Rachel Ulferts United Kingdom 19 591 0.7× 552 0.8× 244 0.5× 224 1.1× 324 1.7× 26 1.4k
Takashi Irie Japan 22 665 0.8× 679 1.0× 523 1.0× 145 0.7× 71 0.4× 55 1.9k
Chandran Ramakrishna United States 21 566 0.7× 545 0.8× 834 1.6× 218 1.1× 69 0.4× 34 1.7k
Anna Albecka United Kingdom 18 495 0.6× 395 0.6× 211 0.4× 88 0.4× 49 0.3× 23 1.6k
Sharmila Nair United States 12 884 1.1× 812 1.2× 958 1.8× 57 0.3× 63 0.3× 14 2.4k
Helena J. Maier United Kingdom 18 835 1.0× 351 0.5× 195 0.4× 515 2.5× 144 0.8× 28 1.3k

Countries citing papers authored by Yize Li

Since Specialization
Citations

This map shows the geographic impact of Yize Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yize Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yize Li more than expected).

Fields of papers citing papers by Yize Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yize Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yize Li. The network helps show where Yize Li may publish in the future.

Co-authorship network of co-authors of Yize Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yize Li. A scholar is included among the top collaborators of Yize Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yize Li. Yize Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rahman, Masmudur M., Honor L. Glenn, Karen V. Kibler, et al.. (2025). Effect of Exportin 1/XPO1 Nuclear Export Pathway Inhibition on Coronavirus Replication. Viruses. 17(2). 284–284.
3.
Li, Yize, Xin Ge, & Ru‐Rong Ji. (2023). Pain management by chemogenetic control of sensory neurons. Cell Reports Medicine. 4(12). 101338–101338. 1 indexed citations
4.
Liu, Qingqing, et al.. (2023). The Role of HBx Protein in Diseases Beyond the Liver. Infection and Drug Resistance. Volume 16. 3225–3232.
5.
Yuan, Jingjing, Shuhan Chen, Zhongyu Wang, et al.. (2022). Intraoperative Intravenous Infusion of Esmketamine Has Opioid-Sparing Effect and Improves the Quality of Recovery in Patients Undergoing Thoracic Surgery: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.. PubMed. 25(9). E1389–E1397. 21 indexed citations
7.
Whelan, Jillian N., David M. Renner, Yize Li, et al.. (2021). Zika virus employs the host antiviral RNase L protein to support replication factory assembly. Proceedings of the National Academy of Sciences. 118(22). 12 indexed citations
8.
Li, Yize, David M. Renner, Courtney E. Comar, et al.. (2021). SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes. Proceedings of the National Academy of Sciences. 118(16). 149 indexed citations
9.
Price, Alexander M., Chao Di, Katharina E. Hayer, et al.. (2021). Adenovirus prevents dsRNA formation by promoting efficient splicing of viral RNA. Nucleic Acids Research. 50(3). 1201–1220. 16 indexed citations
10.
Sherrill-Mix, Scott, Young Sun Hwang, Aoife M. Roche, et al.. (2021). Detection of SARS-CoV-2 RNA using RT-LAMP and molecular beacons. Genome biology. 22(1). 169–169. 62 indexed citations
11.
Daou, Salima, Manisha Talukdar, Jinle Tang, et al.. (2020). A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency. Proceedings of the National Academy of Sciences. 117(40). 24802–24812. 21 indexed citations
12.
Li, Yize, Eveline Kindler, Daphne Cooper, et al.. (2020). Physiologic RNA targets and refined sequence specificity of coronavirus EndoU. RNA. 26(12). 1976–1999. 24 indexed citations
13.
Banerjee, Shuvojit, Elona Gusho, Christina Gaughan, et al.. (2019). OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug. Proceedings of the National Academy of Sciences. 116(11). 5071–5076. 50 indexed citations
14.
Chitrakar, Alisha, Sneha Rath, Jesse Donovan, et al.. (2019). Real-time 2-5A kinetics suggest that interferons β and λ evade global arrest of translation by RNase L. Proceedings of the National Academy of Sciences. 116(6). 2103–2111. 29 indexed citations
15.
Fei, Yuxiang, Yize Li, Hongfei Huang, et al.. (2019). JLX001 Modulated the Inflammatory Reaction and Oxidative Stress in pMCAO Rats via Inhibiting the TLR2/4-NF-κB Signaling Pathway. Neurochemical Research. 44(8). 1924–1938. 19 indexed citations
16.
Case, James Brett, Yize Li, Ruth Elliott, et al.. (2017). Murine Hepatitis Virus nsp14 Exoribonuclease Activity Is Required for Resistance to Innate Immunity. Journal of Virology. 92(1). 49 indexed citations
17.
Li, Yize, Shuvojit Banerjee, Stephen A. Goldstein, et al.. (2017). Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line. eLife. 6. 121 indexed citations
18.
Xu, Jie, Yan Sun, Yize Li, et al.. (2017). Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence. Nature Communications. 8(1). 799–799. 62 indexed citations
20.
Li, Yize, Dorian Counor, Peng Lü, et al.. (2012). Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model. Virology Journal. 9(1). 135–135. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026